JLK to supply healthcare AI solutions for stroke detection to Siloam Hospitals in Indonesia

Korean healthcare AI company JLK has agreed to partner with Indonesia’s largest private hospital network PT Siloam International Hospitals Tbk to supply healthcare AI solutions that include JLK-ICH for brain haemorrhage detection and JLK-UIA for brain aneurysm detection.

Under the MoU signed with medical consulting company PT Kind Communication, JLK will also cooperate in creating a digital healthcare ecosystem in Indonesia.

According to the company’s CEO, Kim Dong-min, Indonesia will be an outpost for JLK to enter Southeast Asia’ medical AI market. JLK plans to expand medical AI exports, he explained, by using the Snappi platform equipped with MEDIHUB STROKE, a full-cycle stroke AI solution, according to the company’s CEO Kim Dong-min. Snappi verifies whether a patient is having a stroke anytime, anywhere, and provides various communication functions such as chat and video-sharing for medical staff.

Siloam Hospitals operates 41 hospitals and 25 clinics, with over 3,000 doctors and 8,000 nurses.

Author

  • Matthew Brady

    Matt Brady is an award-winning storyteller and strategic communications advisor.

    A native Englishman with global experience spanning China, Hong Kong, Iraq, Malaysia, Saudi Arabia, and the UAE, he founded HealthTechAsia and co-founded the non-profit Pul Alliance for Digital Health and Equity.

    He has led social media and communications initiatives for world leaders, corporations, and NGOs, and spearheaded editorial strategy for a portfolio of leading healthcare events and year-round publications — transforming coverage from print to digital — including Arab Health, Asia Health, Africa Health, FIME, and others. Earlier in his career, he held editorial roles at Microsoft and Johnson & Johnson.

    He received the 2021 Medical Travel Media Award from the Malaysia Healthcare Travel Council and a Guardian Student Media Award in 2000.

    View all posts

Discover more from HealthTechAsia

Subscribe to get the latest posts sent to your email.

Leave a Reply

Your email address will not be published. Required fields are marked *